Challenges and directions for the pathogen hypothesis of Alzheimer's disease

Neurobiology of Aging

Volumn 25, Issue 5, 2004, Pages 629-637

  Robinson, Stephen R ^a   Dobson, Curtis ^b   Lyons, Joseph ^c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Amyloid; Bacteria; Chlamydia; Herpes; Infection; Plaque; Virus

Indexed keywords

ACICLOVIR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CHOLINESTERASE INHIBITOR; CLIOQUINOL; IMMUNOSUPPRESSIVE AGENT; PRESENILIN 1; PRESENILIN 2; VIRUS ANTIGEN; VIRUS PROTEIN;

ALZHEIMER DISEASE; ANTIBIOTIC THERAPY; BRAIN; BRAIN TISSUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLINERGIC SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; GRAFT REJECTION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INHERITANCE; LATENT PERIOD; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE PLAQUE; VIRION; VIRUS INFECTION; VIRUS PARTICLE;

EID: 2542466706     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.12.022     Document Type: Article

References (62)

1. Albrecht P., Burnstein T., Klutch M.J., Hicks H.T., Ennis F.A. Subacute sclerosing panencephalitis: experimental infection in primates. Science. 195(4273):1977;64-66
2. Balin B.J., Gerard H.C., Arking E.J., Appelt D.M., Branigan P.J., Abrams J.T., et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl). 187(1):1998;23-42
3. Bishop G.M., Robinson S.R. The amyloid hypothesis: let sleeping dogmas lie. Neurobiol Aging. 23(6):2002;1101-1105
4. Bjorksten B., Marklund S., Hagglof B. Enzymes of leukocyte oxidative metabolism in Down's syndrome. Acta Paediatr Scand. 73(1):1984;97-101
5. Campbell L.A., Kuo C.C., Grayston J.T. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 4(4):1998;571-579
6. Cochrane M, Pospischil A, Walker P. The location and number of sections required to increase the chance of detecting Chlamydia pneumoniae in atherosclerotic carotid arteries. In: Schachter J, Christiansen G, Clarke IN, editors. Chlamydia infections. Proceedings of 10th International Symposium on Human Chlamydial Infections. Antalya, Turkey; 2002. p. 301-4.
7. Connolly J.H., Allen I.V., Hurwitz L.J., Millar J.H.D. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet. 289:1967;524-544
8. Corsellis J.A. The transmissibility of dementia. Br. Med. Bull. 42(1):1986;111-114
9. Deatly A.M., Haase A.T., Fewster P.H., Lewis E., Ball M.J. Human herpes virus infections and Alzheimer's disease. Neuropathol Appl Neurobiol. 16(3):1990;213-223
10. Dobson C.B., Itzhaki R.F. Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging. 20(4):1999;457-465
11. Dyrberg T., Petersen J.S., Oldstone M.B. Immunological cross-reactivity between mimicking epitopes on a virus protein and a human autoantigen depends on a single amino acid residue. Clin Immunol Immunopathol. 54(2):1990;290-297
12. Finefrock A.E., Bush A.I., Doraiswamy P.M. Current status of metals as therapeutic targets in Alzheimer's disease. J. Am. Geriatr Soc. 51(8):2003;1143-1148
13. Fraser N.W., Lawrence W.C., Wroblewska Z., Gilden D.H., Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proc. Natl. Acad. Sci. USA. 78(10):1981;6461-6465
14. Gabbianelli R., Kantar A., Oggiano N., Fiorini R., Falcioni G., Giorgi P.L. Oxidative metabolism in polymorphonuclear granulocytes of children with trisomy 21. Minerva Pediatr. 45(12):1993;493-497
15. Gajdusek D.C. Unconventional viruses and the origin and disappearance of kuru. Science. 197:1977;943-960
16. Gebhardt B.M. Evidence for antigenic cross-reactivity between herpesvirus and the acetylcholine receptor. J. Neuroimmunol. 105(2):2000;145-153
17. Giacobini E. Cholinergic function and Alzheimer's disease. Int. J. Geriatr Psychiatry. 18(Suppl. 1):2003;S1-S5
18. Gieffers J., Reusche E., Solbach W., Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J. Clin Microbiol. 38(2):2000;881-882
19. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol Neurosurg Psychiatry. 74(6):2003;788-789
20. Itzhaki R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B., Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 349(9047):1997;241-244
21. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging, this issue.
22. Krucke W. Herpes simplex virus und Nervensystem. Jarbuch der Max Planck Gesellschaft zur Forderung der Wissenschaften 1960;70-84.
23. Lellouch-Tubiana A., Fohlen M., Robain O., Rozenberg F. Immunocytochemical characterization of long-term persistent immune activation in human brain after Herpes simplex encephalitis. Neuropathol Appl Neurobiol. 26(3):2000;285-294
24. Libikova H., Pogady J., Wiedermann V., Breier S. Search for herpetic antibodies in the cerebrospinal fluid in senile dementia and mental retardation. Acta Virol. 19(6):1975;493-495
25. Liedtke W., Opalka B., Zimmermann C.W., Lignitz E. Age distribution of latent Herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J. Neurol Sci. 116(1):1993;6-11
26. Lin W.R., Wozniak M.A., Esiri M.M., Klenerman P., Itzhaki R.F. Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J. Neurol Neurosurg Psychiatry. 70(1):2001;117-119
27. Little C.S., Hammond C.J., MacIntyre A., Balin B.J., Appelt D.M. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging. 25(4):2004;419-429
28. Ljungman P. Beta-herpesvirus challenges in the transplant recipient. J. Infect Dis. 186(Suppl. 1):2002;S99-S109
29. Lycke E., Norrby R., Roos B.E. A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br. J. Psychiatry. 124(0):1974;273-279
30. Mahony J, Woulfel J, Munoz D, Chong S, Smieja M. Chlamydia pneumoniae in the Alzheimer's brain - is detection hampered by low copy number? In: Proceedings of 4th Meeting of the European Society for Chlamydia Research, Helsinki, Finland; 2000. p. 299-300.
31. Malinverni R., Kuo C.C., Campbell L.A., Lee A., Grayston J.T. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrob Agents Chemother. 39(1):1995;45-49
32. Mann D.M., Tinkler A.M., Yates P.O. Neurological disease and Herpes simplex virus. An immunohistochemical study. Acta Neuropathol (Berl). 60(1/2):1983;24-28
33. Marx J.L. Slow viruses II: the unconventional agents. Science. 181:1973;44-45
34. Meyding-Lamade U., Lamade W., Kehm R., Knopf K.W., Hess T., Gosztonyi G., et al. Herpes simplex virus encephalitis: cranial magnetic resonance imaging and neuropathology in a mouse model. Neurosci Lett. 248(1):1998;13-16
35. Meyer M.A., Hubner K.F., Raja S., Hunter K., Paulsen W.A. Sequential positron emission tomographic evaluations of brain metabolism in acute herpes encephalitis. J. Neuroimaging. 4:1994;104-105
36. Middleton P.J., Petric M., Kozak M., Rewcastle N.B., McLachlan D.R. Herpes-simplex viral genome and senile and presenile dementias of Alzheimer and Pick. Lancet. 1(8176):1980;1038
37. Mills E.L., Quie P.G. Congenital disorders of the function of polymorphonuclear neutrophils. Rev Infect Dis. 2(3):1980;505-517
38. Nochlin D., Shaw C.M., Campbell L.A., Kuo C.C. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology. 53(8):1999;1888
39. Ossewaarde JM, Gielis-Proper SK, Meijer A, Roholl PJM. Chlamydia pneumoniae antigens are present in the brains of Alzheimer patients, but not in the brains of patients with other dementias. In: Proceedings of 4th Meeting of the European Society for Chlamydia Research, Helsinki, Finland; 2000. p. 301-2.
40. Penney J.B. Jr., Weiner L.P., Herndon R.M., Narayan O., Johnson R.T. Virions from progressive multifocal leukoencephalopathy: rapid serological identification by electron microscopy. Science. 178(56):1972;60-62
41. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 4(2):2003;103-112
42. Pogo B.G., Casals J., Elizan T.S. A study of viral genomes and antigens in brains of patients with Alzheimer's disease. Brain. 110:1987;907-915
43. Prebeck S., Kirschning C., Durr S., da Costa C., Donath B., Brand K., et al. Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J. Immunol. 167(6):2001;3316-3323
44. Renvoize E.B., Awad I.O., Hambling M.H. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing. 16(5):1987;311-314
45. Ribalta T., Martinez A.J., Jares P., Muntane J., Miquel R., Claramonte X., et al. Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation. An autopsy study of 83 cases. Virchows Arch. 440(2):2002;166-171
46. Ring R.H., Lyons J.M. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J. Clin Microbiol. 38(7):2000;2591-2594
47. Robinson S.R., Bishop G.M. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging. 23(6):2002;1051-1072
48. Robinson S.R., Bishop G.M., Munch G. Alzheimer vaccine: amyloid-beta on trial. Bioessays. 25(3):2003;283-288
49. Rottenberg M.E., Gigliotti-Rothfuchs A., Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol. 14(4):2002;444-451
50. Saikku P. Chlamydia pneumoniae - an update on clinical disease. In: Schachter J, Christiansen G, Clarke IN, editors. Chlamydia infections. Proceedings of 10th International Symposium on Human Chlamydial Infections, Antalya, Turkey; 2000. p. 443-53.
51. Schmutzhard E. Viral infections of the CNS with special emphasis on Herpes simplex infections. J. Neurol. 248(6):2001;469-477
52. Schwimmbeck P.L., Dyrberg T., Drachman D.B., Oldstone M.B. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with Herpes simplex virus. J. Clin Invest. 84(4):1989;1174-1180
53. Sequiera L.W., Jennings L.C., Carrasco L.H., Lord M.A., Curry A., Sutton R.N. Detection of herpes-simplex viral genome in brain tissue. Lancet. 2(8143):1979;609-612
54. Singh N., Paterson D.L. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation. 69(12):2000;2474-2479
55. Sriram S., Stratton C.W., Yao S., Tharp A., Ding L., Bannan J.D., et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46(1):1999;6-14
56. Sulowicz W., Ignacak E., Kuzniewski M., Szymczakiewicz-Multanowska A., Zawilinska B., Kryczko E., et al. Cytomegalovirus infection in kidney transplant patients: clinical manifestations and diagnosis. Zentralbl Bakteriol. 287(4):1998;489-500
57. Taylor G.R., Crow T.J., Markakis D.A., Lofthouse R., Neeley S., Carter G.I. Herpes simplex virus and Alzheimer's disease: a search for virus DNA by spot hybridisation. J. Neurol Neurosurg Psychiatry. 47(10):1984;1061-1065
58. Taylor G.S., Vipond I.B., Paul I.D., Matthews S., Wilcock G.K., Caul E.O., et al. Failure to correlate C. pneumoniae with late onset Alzheimer's disease. Neurology. 59(1):2002;142-143
59. Wagner E.K., Bloom D.C. Experimental investigation of Herpes simplex virus latency. Clin Microbiol Rev. 10(3):1997;419-443
60. Whitley R.J., Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 359(9305):2002;507-513
61. Wolf R., Wolf D., Orion E., Matz H. Long-term prophylactic antiviral therapy for recurrent Herpes simplex: the controversy goes on. Clin Dermatol. 21(2):2003;164-167
62. Yamaguchi H., Friedman H., Yamamoto Y. Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells. Infect Immun. 71(6):2003;3645-3647